Original language | Undefined/Unknown |
---|---|
Journal | Journal of Clinical Oncology |
Publication status | Published - 2022 |
Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7) with high rate of signet cell component: Final results of the multicenter, randomized phase II/III trial of the German AIO and Italian GOIM
Thorsten Oliver Goetze, Ralf-Dieter Hofheinz, Harald Schmalenberg, Dirk Strumberg, Eray Goekkurt, Stefan Angermeier, Thomas Zander, Jochem Potenberg, Hans-Georg Kopp, Daniel Pink, Gabriele Margareta Siegler, Michael Schenk, Ferdinando De Vita, Evaristo Maiello, Timo Gaiser, Disorn Sookthai, Tanita Brulin, Claudia Pauligk, Nils Homann, Salah-Eddin Al-Batran
Research output: Contribution to journal › Original Article › peer-review
2
Citations
(Web of Science)